Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: A pilot study - 29/05/14
Doi : 10.1016/j.jaci.2014.03.026
Jean-Pierre Allam, MD a, ∗ 
, Eike Wuestenberg, MD b, c, ∗, Hendrik Wolf, PhD c, Ludger Klimek, MD d, Elke Decot, MD e, Andreas Horn, MD f, Jörg Schnitker, PhD g, Thomas Bieber, MD, PhD, MDRA a, Natalija Novak, MD a
, Eike Wuestenberg, MD b, c, ∗, Hendrik Wolf, PhD c, Ludger Klimek, MD d, Elke Decot, MD e, Andreas Horn, MD f, Jörg Schnitker, PhD g, Thomas Bieber, MD, PhD, MDRA a, Natalija Novak, MD a a Department of Dermatology and Allergy, University of Bonn, Bonn, Germany
b Department of Otorhinolaryngology, University of Dresden, Dresden, Germany
c ALK-Abelló, Hamburg, Germany
d Center for Rhinology and Allergy, Wiesbaden, Germany
e Private Practice for Rhinology, Dreieich, Germany
f Private Practice for Rhinology, Heidelberg, Germany
g Institut für angewandte Statistik GmbH, Bielefeld, Germany
| This study was supported by ALK-Abelló, Hamburg, Germany, and ALK-Abelló, Hørsholm, Denmark. |
|
| Disclosure of potential conflict of interest: J.-P. Allam has received research support from ALK-Abelló and DFG, consultancy fees from ALK-Abelló, and lecture fees from ALK-Abelló, HAL Allergy, and Stallergenes. E. Wuestenberg is employed by the sponsor of this study. Hendrik Wolf is employed by ALK-Abelló. L. Klimek has received honoraria and/or research support from ALK-Abelló, Allergopharma, Artu-Biologicals, Bencard, Biomay, Bionorica, Boehringer Ingelheim, Cytos, GSK, HAL Allergy, The Netherlands, Hartington, Leti, Lofarma, Novartis, MEDA, MSD, Optima, Phadia, and Roxall. A. Horn has received travel support, consultancy fees, and lecture fees. J. Schnitker has received consultancy fees, participation fees, payment for manuscript preparation, and research support from ALK-Abelló. N. Novak has received research support from ALK-Abelló; has received consultancy fees from ALK-Abelló, Leti, and HAL Allergy; and has received lecture fees from ALK-Abelló, HAL Allergy, Bencard, and Allergopharma. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 133 - N° 6
P. 1757 - juin 2014 Retour au numéro
Article précédent
- The effects of calcitriol treatment in glucocorticoid-resistant asthma
- Alexandra M. Nanzer, Emma S. Chambers, Kimuli Ryanna, Anna T. Freeman, Grainne Colligan, David F. Richards, Peter M. Timms, Adrian R. Martineau, Christopher J. Griffiths, Christopher J. Corrigan, Catherine M. Hawrylowicz
- Basophils are elevated in nasal polyps of patients with chronic rhinosinusitis without aspirin sensitivity
- Mahboobeh Mahdavinia, Roderick G. Carter, Christopher J. Ocampo, Whitney Stevens, Atsushi Kato, Bruce K. Tan, Robert C. Kern, David B. Conley, Rakesh Chandra, Kathryn E. Hulse, Lydia A. Suh, James E. Norton, Anju T. Peters, Leslie C. Grammer, Lawrence B. Schwartz, Robert P. Schleimer
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?